← Back to Search

Behavioral Intervention

Mobile App for Sexual Dysfunction

N/A
Waitlist Available
Led By Lavanya P Parsons, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient with a current or historic diagnosis of breast cancer or gynecologic cancer (uterine ovarian, fallopian tube, peritoneal, cervical, vulva, or vaginal cancers)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to identify breast and gynecologic cancer patients who have sexual problems. They will use a specific questionnaire to measure these problems and offer patients the chance to speak with a healthcare provider to find

Who is the study for?
This trial is for women who have breast or gynecologic cancers and are experiencing sexual dysfunction. Participants will use the Rosy mobile application, which aims to help with these issues.
What is being tested?
The study tests the feasibility of using the Rosy app to address sexual dysfunction in affected patients. It involves measuring sexual function with a questionnaire and providing follow-up care.
What are the potential side effects?
Since this trial involves using an app rather than medication, traditional side effects are not expected. However, users may experience emotional or psychological responses to content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have or had breast or gynecologic cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI)
Change in sexual dysfunction as assessed by the Social Determinants of Health (SDOH) questionnaire
Secondary study objectives
Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI) in ethnic minority groups
Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI) in sexual and gender minority groups
Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI) in unpartnered women

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Rosy appExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
347,837 Total Patients Enrolled
Lavanya P Parsons, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~13 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top